AIM: A multicountry observational study was conducted to gain insight into the current
management of elevated low density lipoprotein cholesterol (LDL-C) in high-risk (HR) and …

Background The WHO recommends that those with established cardiovascular disease
should be treated with lipid-lowering therapy, but there is no specific guidance regarding …

OBJECTIVE To determine the proportion of the population, firstly, with cholesterol⩾ 5.0
mmol/l and, secondly, with any cholesterol concentration, who might benefit from statin …

The recent report on lipid lowering therapy from the Netherlands Health Council is largely in
agreement with the 1998 guidelines made at the Dutch Institute for Health Care …

Aims We sought to evaluate physicians' opinions and practices in lipid management.
Methods and results A web-based survey by the European Society of Cardiology (ESC) and …

Background. Few published data in particular from the United States indicate that the
implementation of guidelines for prevention of coronary heart disease (CHD) is far from …

BACKGROUND: A hospital-based screening project (HSP) in Austria found 47% of high-risk
patients (LDL-C< 100 mg/dl) and 24% of very high-risk patients (LDL-C< 70 mg/dl) at goal …

BACKGROUND: Information on lipid-lowering treatment (LLT) patterns (statin titration, statin
switching, combination therapy and no change) in clinical practice is limited. The objectives …

Background Recent studies have confirmed that treatment with lipid-lowering drugs
decreases cardiovascular morbidity and mortality in primary as well as secondary …

Objective To compare nine different algorithms for determining the necessity for drug
treatment of hyperlipidaemia in patients without cardiovascular disease. Design Risk-factor …